🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Yang_lab Prof Yang (our co-Founder & Chief Scientific Advisor) just gave an oral talk out of 19 oral & poster presentations at ASGCT meeting of a novel glycosylase-based guanine base editor(gGBE) which just published online yesterday. #ASGCT23 CRISPR News 🧬 The CRISPR Journal

I still remember 19-20 yrs ago when only 10 people registered to #ASGCT meeting. At #ASGCT23, I ran into my 2 bosses, Kathy High & Glenn Pierce, and attended many #presentations reflecting the significant advances in #GeneTherapy Thanks ASGCT for the hard work. #CRISPR

Once again, congratulations to HuidaGene Therapeutics and the team (Yang_lab , Yingsi Zhou and Huawei Tong ) who are dedicating to bring #CRISPR editing #technology to #patients worldwide. #Baseediting #GeneTherapy #GeneEditing

Congrats! CRISPR News 🧬 The CRISPR Journal #GeneTherapy #GeneEditing #CrisprCas9 nature Nature Portfolio

After gardening the entire morning, time to relax with the heat and read some manuscripts!

After 4-day of BD marathon at #BIO2023 , I’m motivated by the tremendous interests from #pharmaceuticals around the world to learn the progress of HuidaGene Therapeutics #innovation in #GenomeMedicine which is in development for one-and-done treatment to potentially cure patients worldwide.

I look forward to reuniting my acquaintance, meeting new friends, and providing suggestions on those companies with roadshows on this Saturday (08-July) 6th Sino-American Pharmaceutical Professionals Association (SAPA) Investment Forum & Roadshow. #invest…lnkd.in/enP8uKNC

Exciting for a new deaminase-free glycosylase-based base editor. Excellent talk Yang_lab and HuidaGene Therapeutics #ESGCT #ESGCT2023 #CRISPR #GeneTherapy #GeneEditing

We have completed enrollment and dosing the last #patient in the LIGHT #AAV #genetherapy trial for #inherited #blindness ahead of schedule. We're grateful for our patients of their #support and #trust in us. #RareDiseases #RareDisease #biotechnology #pharmaceuticals #medicine

A big thank you to our MDS team for pioneering the development of HG204 (#CRISPR #RNA -#GeneEditing therapy for MDS) and communicating with U.S. FDA , without whom none of this would've been possible. We look forward to bringing HG204 into clinic soon. #RareDisease #neuroscience

Great discussion today!

Who's going??? See y'al there!

See you in London?

We're excited to share the progress of our ophthalmology program at 2o Congreso Europeo Pacientes Mácula Retina by Mácula Retina , bringing hopes to patients suffering from #blindness or #visual #disabilities . #ceguera #discapacidad #biotecnologia #genetherapy #genomicmedicines

Our 3 #ophthalmology programs using #AAV #genetherapy , #CRISPR #DNA #geneediting , and CRISPR #RNA #gene -editing have the potentials to cure #blindness and hopefully bring #hope to #patients .

It was my pleasure to present the progress of #Ophthalmology programs at HuidaGene Therapeutics using #CRISPR 3.0 to treat #retinal #diseases at the Second European Congress #MáculaRetina23 ⬇️ in #Seville. Thanks for the invitation, @Macularetina ! #visual #blindness #genetherapy

Spending my alternative gobble gobble 🦃 #thanksgiving2023 with oink oink 🐷 #jamon and #love . Let’s spread 💕 #BlackFriday

Who is going? See you in #SanFrancisco

Muscle strength is crucial for almost everything we do: from communication and work to mobility, from hugging loved ones to breathing. We look forward to advancing HG302 quickly and safely into the clinic soon. #DMD #musculardystrophy #rare #CRISPR #patient #medicine #future

HuidaGene Announces RPDD Granted to HG302, A Novel CRISPR DNA-editing Therapy, for the Treatment of DMD prn.to/48muAdK